A puzzle in children's eyes
In 1971 Alfred Knudson studied retinoblastoma, a rare eye cancer in young children. He noticed two patterns. Some children had the cancer in both eyes and developed it very early; their disease often ran in families. Others had it in one eye only, later, with no family history. Knudson asked: what single rule could explain both?
His answer became the two-hit hypothesis (also called the Knudson hypothesis). A single retinal cell must lose both working copies of the RB tumor-suppressor gene before a tumor forms. Two independent damaging events — two hits — are required. From that one rule, both patterns fall out naturally.
Why one rule explains both patterns
- Hereditary case: the child inherits one already-broken RB copy as a germline mutation, so it sits in every cell from birth. Only one more hit — a single somatic mutation in any retinal cell — is needed to lose the second copy. With millions of retinal cells, that second hit is almost certain to happen somewhere, often in both eyes and early in life.
- Sporadic case: the child is born with two healthy RB copies. Now the same single cell must suffer two separate hits, one after another. That double coincidence is rare, so it usually strikes just one eye, in only one spot, and later in childhood.
- The hereditary child looks like they inherited “cancer,” but what they really inherited is one missing brake — a head start of one hit. The cancer itself still requires a second, somatic event in a specific cell.
Often the second hit is not a fresh small mutation but the loss of the entire good copy, when the cell duplicates the already-broken chromosome region or loses the healthy one. This common second-hit mechanism is called loss of heterozygosity: the cell goes from having one good and one bad copy to having no good copy at all.
p53, the guardian of the genome
No single gene illustrates a tumor suppressor's job better than p53, nicknamed the guardian of the genome. When a cell's DNA is damaged, p53 senses it and acts as an emergency supervisor: it can pause the cell cycle to allow DNA repair, and if the damage is too severe, it can trigger the cell's own self-destruct program so a dangerous cell never divides. It is a brake, a repair foreman, and an executioner rolled into one.
Because p53 sits at the center of so many safeguards, it is the most commonly mutated gene across human cancers — disabled in roughly half of all tumors. When p53 fails, damaged cells that should have paused or died instead keep dividing, passing their errors on. People who inherit a single faulty p53 copy have Li–Fraumeni syndrome, a hereditary cancer syndrome with high risk of several cancer types — a living demonstration of the two-hit logic applied to the genome's chief guardian.